46. Malignant rheumatoid arthritis Clinical trials / Disease details
Clinical trials : 4,356 / Drugs : 2,567 - (DrugBank : 415) / Drug target genes : 192 - Drug target pathways : 228
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT04514614 (ClinicalTrials.gov) | September 1, 2020 | 7/8/2020 | Characterizing Rheumatoid Arthritis With 68Ga-FAPI PET/CT | Characterizing Rheumatoid Arthritis With 68Ga-FAPI PET/CT | Arthritis | Drug: 68Ga-FAPI | Peking Union Medical College Hospital | NULL | Recruiting | 18 Years | 90 Years | All | 100 | Early Phase 1 | China |